157 related articles for article (PubMed ID: 37383677)
1.
Chi HT; Tram VN; Quan NT; Ly BTK
Biomed Rep; 2023 Jul; 19(1):47. PubMed ID: 37383677
[TBL] [Abstract][Full Text] [Related]
2. ETV6-NTRK3 as a therapeutic target of small molecule inhibitor PKC412.
Chi HT; Ly BT; Kano Y; Tojo A; Watanabe T; Sato Y
Biochem Biophys Res Commun; 2012 Dec; 429(1-2):87-92. PubMed ID: 23131561
[TBL] [Abstract][Full Text] [Related]
3. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland.
Bell D; Ferrarotto R; Liang L; Goepfert RP; Li J; Ning J; Broaddus R; Weber RS; El-Naggar AK
Virchows Arch; 2020 Feb; 476(2):295-305. PubMed ID: 31423558
[TBL] [Abstract][Full Text] [Related]
4. A highly conserved NTRK3 C-terminal sequence in the ETV6-NTRK3 oncoprotein binds the phosphotyrosine binding domain of insulin receptor substrate-1: an essential interaction for transformation.
Lannon CL; Martin MJ; Tognon CE; Jin W; Kim SJ; Sorensen PH
J Biol Chem; 2004 Feb; 279(8):6225-34. PubMed ID: 14668342
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the SAM domain of the ETV6-NTRK3 chimeric tyrosine kinase block polymerization and transformation activity.
Tognon CE; Mackereth CD; Somasiri AM; McIntosh LP; Sorensen PH
Mol Cell Biol; 2004 Jun; 24(11):4636-50. PubMed ID: 15143160
[TBL] [Abstract][Full Text] [Related]
6. A new ETV6-NTRK3 cell line model reveals MALAT1 as a novel therapeutic target - a short report.
Chen S; Nagel S; Schneider B; Dai H; Geffers R; Kaufmann M; Meyer C; Pommerenke C; Thress KS; Li J; Quentmeier H; Drexler HG; MacLeod RAF
Cell Oncol (Dordr); 2018 Feb; 41(1):93-101. PubMed ID: 29119387
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory and anti-nociceptive activities of methanol extract from aerial part of Phlomis younghusbandii Mukerjee.
Wang QS; Yang L; Cui WY; Chen L; Jiang YH
PLoS One; 2014; 9(3):e89149. PubMed ID: 24598860
[TBL] [Abstract][Full Text] [Related]
8. Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma.
Yamamoto H; Nozaki Y; Sugii A; Taguchi K; Hongo T; Jiromaru R; Sato M; Nakano T; Hashimoto K; Fujiwara M; Oda Y
Hum Pathol; 2021 Mar; 109():37-44. PubMed ID: 33301751
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor 1 receptor stabilizes the ETV6-NTRK3 chimeric oncoprotein by blocking its KPC1/Rnf123-mediated proteasomal degradation.
Tognon CE; Rafn B; Cetinbas NM; Kamura T; Trigo G; Rotblat B; Okumura F; Matsumoto M; Chow C; Davare M; Pollak M; Mayor T; Sorensen PH
J Biol Chem; 2018 Aug; 293(32):12502-12515. PubMed ID: 29903916
[TBL] [Abstract][Full Text] [Related]
10. Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.
Church AJ; Calicchio ML; Nardi V; Skalova A; Pinto A; Dillon DA; Gomez-Fernandez CR; Manoj N; Haimes JD; Stahl JA; Dela Cruz FS; Tannenbaum-Dvir S; Glade-Bender JL; Kung AL; DuBois SG; Kozakewich HP; Janeway KA; Perez-Atayde AR; Harris MH
Mod Pathol; 2018 Mar; 31(3):463-473. PubMed ID: 29099503
[TBL] [Abstract][Full Text] [Related]
11. ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation.
Morrison KB; Tognon CE; Garnett MJ; Deal C; Sorensen PH
Oncogene; 2002 Aug; 21(37):5684-95. PubMed ID: 12173038
[TBL] [Abstract][Full Text] [Related]
12. Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas.
Krings G; Joseph NM; Bean GR; Solomon D; Onodera C; Talevich E; Yeh I; Grenert JP; Hosfield E; Crawford ED; Jordan RC; van Zante A; Zaloudek C; Shin SJ; Chen YY
Mod Pathol; 2017 Aug; 30(8):1086-1099. PubMed ID: 28548128
[TBL] [Abstract][Full Text] [Related]
13. Mutation of the salt bridge-forming residues in the ETV6-SAM domain interface blocks ETV6-NTRK3-induced cellular transformation.
Cetinbas N; Huang-Hobbs H; Tognon C; Leprivier G; An J; McKinney S; Bowden M; Chow C; Gleave M; McIntosh LP; Sorensen PH
J Biol Chem; 2013 Sep; 288(39):27940-50. PubMed ID: 23798677
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of Andrographis paniculata extract and its active diterpenoids on platelet aggregation.
Thisoda P; Rangkadilok N; Pholphana N; Worasuttayangkurn L; Ruchirawat S; Satayavivad J
Eur J Pharmacol; 2006 Dec; 553(1-3):39-45. PubMed ID: 17081514
[TBL] [Abstract][Full Text] [Related]
15. Andrographis paniculata diterpenoids and ethanolic extract inhibit TNFα-induced ICAM-1 expression in EA.hy926 cells.
Lin HC; Li CC; Yang YC; Chiu TH; Liu KL; Lii CK; Chen HW
Phytomedicine; 2019 Jan; 52():157-167. PubMed ID: 30599895
[TBL] [Abstract][Full Text] [Related]
16. Expanding the Molecular Spectrum of Secretory Carcinoma of Salivary Glands With a Novel VIM-RET Fusion.
Skálová A; Banečkova M; Thompson LDR; Ptáková N; Stevens TM; Brcic L; Hyrcza M; Michal M; Simpson RHW; Santana T; Michal M; Vaněček T; Leivo I
Am J Surg Pathol; 2020 Oct; 44(10):1295-1307. PubMed ID: 32675658
[TBL] [Abstract][Full Text] [Related]
17. The Impact of ETV6-NTRK3 Oncogenic Gene Fusions on Molecular and Signaling Pathway Alterations.
Kinnunen M; Liu X; Niemelä E; Öhman T; Gawriyski L; Salokas K; Keskitalo S; Varjosalo M
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686522
[TBL] [Abstract][Full Text] [Related]
18. Effect of andrographolide and deep eutectic solvent extracts of Andrographis paniculata on human coronavirus organ culture 43 (HCoV-OC43).
Komaikul J; Ruangdachsuwan S; Wanlayaporn D; Palabodeewat S; Punyahathaikul S; Churod T; Choonong R; Kitisripanya T
Phytomedicine; 2023 Apr; 112():154708. PubMed ID: 36805485
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: A comparative study of salivary gland cancers.
Kawahara A; Taira T; Abe H; Takase Y; Kurita T; Sadashima E; Hattori S; Imamura I; Matsumoto S; Fujisaki H; Sueyoshi K; Akiba J; Kage M
Cancer Cytopathol; 2015 Oct; 123(10):603-11. PubMed ID: 26252941
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic and Molecular Characterization of Four Cases of Pediatric Salivary Secretory Carcinoma (SSC), One with ETV6-RET Fusion.
Salgado CM; Alaggio R; Reyes-Múgica M; Zin A; de Vito R
Head Neck Pathol; 2021 Sep; 15(3):796-802. PubMed ID: 33459993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
